Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
NVCR

Novocure

$31.95

-0.05 (-0.16%)

09:01
06/20/18
06/20
09:01
06/20/18
09:01
Conference/Events
Novocure management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

Over a week ago
NVCR

Novocure

$32.00

0.6 (1.91%)

07:32
06/04/18
06/04
07:32
06/04/18
07:32
Hot Stocks
Novocure to present INNOVATE-3 Phase 3 pivotal trial design »

Novocure will present the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
TECH

Bio-Techne

$152.35

-0.75 (-0.49%)

, QHC

Quorum Health

$4.50

-0.59 (-11.59%)

07:45
05/22/18
05/22
07:45
05/22/18
07:45
Conference/Events
UBS to hold a conference »

Global Healthcare…

TECH

Bio-Techne

$152.35

-0.75 (-0.49%)

QHC

Quorum Health

$4.50

-0.59 (-11.59%)

NVCR

Novocure

$29.60

0.2 (0.68%)

ABBV

AbbVie

$106.18

0.23 (0.22%)

CRVL

CorVel

$53.85

0.9 (1.70%)

PACB

Pacific Biosciences

$2.64

0.03 (1.15%)

CIVI

Civitas Solutions

$15.60

0.25 (1.63%)

RHHBY

Roche

$0.00

(0.00%)

HZNP

Horizon Pharma

$15.01

-0.09 (-0.60%)

NEOS

Neos Therapeutics

$7.20

-0.4 (-5.26%)

ARNA

Arena Pharmaceuticals

$46.23

0.69 (1.52%)

BMY

Bristol-Myers

$52.25

-0.45 (-0.85%)

EXAS

Exact Sciences

$52.27

-0.14 (-0.27%)

RVNC

Revance

$30.40

-0.5 (-1.62%)

LLY

Eli Lilly

$81.83

-0.23 (-0.28%)

PDLI

PDL BioPharma

$2.77

(0.00%)

LNTH

Lantheus

$14.15

-0.1 (-0.70%)

AKBA

Akebia

$10.42

-0.26 (-2.43%)

LMAT

LeMaitre

$33.97

-0.46 (-1.34%)

OSUR

OraSure

$16.22

-0.06 (-0.37%)

NSTG

NanoString

$11.70

-0.44 (-3.62%)

SENS

Senseonics

$3.32

0.07 (2.15%)

VRAY

ViewRay

$7.10

-0.12 (-1.66%)

ARGX

Argenx

$96.14

1.4 (1.48%)

AMEH

Apollo Medical

$15.77

0.07 (0.45%)

SIEGY

Siemens

$0.00

(0.00%)

XOMA

Xoma

$24.24

-0.515 (-2.08%)

MNK

Mallinckrodt

$15.88

0.18 (1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 29

    May

  • 30

    May

  • 30

    May

  • 31

    May

  • 31

    May

  • 04

    Jun

  • 05

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 08

    Jun

  • 12

    Jun

  • 18

    Jun

  • 19

    Jun

  • 10

    Jul

  • 22

    Aug

  • 10

    Sep

ABBV

AbbVie

$99.43

-0.2 (-0.20%)

, SRDX

Surmodics

$43.45

1 (2.36%)

07:51
05/09/18
05/09
07:51
05/09/18
07:51
Conference/Events
Deutsche Bank to hold a conference »

43rd Annual Healthcare…

ABBV

AbbVie

$99.43

-0.2 (-0.20%)

SRDX

Surmodics

$43.45

1 (2.36%)

WVE

Wave Life Sciences

$43.70

1.1 (2.58%)

BTG

B2Gold

$2.85

0.01 (0.35%)

USPH

U.S. Physical Therapy

$91.25

-0.25 (-0.27%)

VNDA

Vanda Pharmaceuticals

$16.15

0.45 (2.87%)

BAYRY

Bayer

$0.00

(0.00%)

NVCR

Novocure

$28.30

0.15 (0.53%)

CMRX

Chimerix

$4.73

-0.04 (-0.84%)

HOLX

Hologic

$36.95

0.02 (0.05%)

IMGN

ImmunoGen

$9.91

-0.28 (-2.75%)

JNJ

Johnson & Johnson

$122.60

-1.05 (-0.85%)

LCI

Lannett

$13.80

-1.85 (-11.82%)

AQXP

Aquinox

$13.17

0.13 (1.00%)

XNCR

Xencor

$29.51

-1.24 (-4.03%)

UHS

Universal Health

$115.89

-1.465 (-1.25%)

ICPT

Intercept

$70.16

-0.14 (-0.20%)

ALKS

Alkermes

$44.21

0.41 (0.94%)

MTD

Mettler-Toledo

$545.70

-7.18 (-1.30%)

ATRS

Antares Pharma

$2.44

0.09 (3.83%)

BLUE

Bluebird Bio

$172.10

-2.15 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 09

    May

  • 10

    May

  • 10

    May

  • 15

    May

  • 16

    May

  • 18

    May

  • 20

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 23

    May

  • 29

    May

  • 05

    Jun

  • 12

    Jun

  • 19

    Jun

  • 21

    Jul

  • 31

    Jan

NVCR

Novocure

$24.20

-0.3 (-1.22%)

06:11
04/26/18
04/26
06:11
04/26/18
06:11
Earnings
Novocure reports Q1 EPS (23c), consensus (13c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 08

    May

  • 21

    May

NVCR

Novocure

$23.75

0.45 (1.93%)

05:05
04/19/18
04/19
05:05
04/19/18
05:05
Upgrade
Novocure rating change at Deutsche Bank »

Novocure upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 08

    May

  • 21

    May

NVCR

Novocure

$21.60

0.05 (0.23%)

07:49
04/17/18
04/17
07:49
04/17/18
07:49
Conference/Events
Novocure management to meet with Deutsche Bank »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

  • 26

    Apr

  • 08

    May

  • 21

    May

NVCR

Novocure

$21.60

0.05 (0.23%)

07:43
04/17/18
04/17
07:43
04/17/18
07:43
Hot Stocks
Novocure announces STELLAR phase 2 trial exceed interim analysis »

Novocure announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 08

    May

  • 21

    May

NVCR

Novocure

$21.55

-0.35 (-1.60%)

16:34
04/13/18
04/13
16:34
04/13/18
16:34
Hot Stocks
Novocure to present data on tumor treating fields at AACR »

Novocure announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 08

    May

  • 21

    May

NVCR

Novocure

$21.95

0.25 (1.15%)

06:54
03/26/18
03/26
06:54
03/26/18
06:54
Recommendations
Novocure analyst commentary at Mizuho »

Mizuho 'very…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.